Duke University Cancer Center — Durham, North Carolina

Duke University Cancer Center is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke University Cancer Center has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer, Acute Myeloid Leukemia.

Sponsors: QED Therapeutics, a BridgeBio company, Duke University, H3 Biomedicine Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Cancer Center?

Duke University Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Cancer Center conducted?

Duke University Cancer Center has 9 clinical trials on record, with 2 currently active. Their work covers Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer, Acute Myeloid Leukemia.

Is Duke University Cancer Center accredited by Crixeo Clinical Trials?

Duke University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.